Literature DB >> 17851140

Effect of sildenafil on hypoxia-induced changes in pulmonary circulation and right ventricular function.

Frank Reichenberger1, Markus G Kohstall, Timon Seeger, Horst Olschewski, Friedrich Grimminger, Werner Seeger, Hossein A Ghofrani.   

Abstract

Hypoxia leads to pulmonary vasoconstriction in healthy men. However, the consequences on right ventricular function are not known. The effects of hypoxia on systolic pulmonary artery pressure (sPAP) and right ventricular function index (TEI) were assessed by Doppler echocardiography. Fourteen members of a Mount Everest expedition were monitored during acute hypoxic challenge at sea level, environmental hypoxia exposure at altitudes of 3440 m and 5245 m and 2 weeks after return to sea level. Subjects received either placebo or 50mg sildenafil in a double-blind randomised cross-over design. Under normoxia at baseline, mean sPAP was 17.1(S.E.M. 1.3) mm Hg, and TEI was 0.13(0.004). Both increased during acute hypoxia: sPAP 29.6(2.6) mm Hg, and TEI 0.35(0.06) (each p<0.01). At 5245 m sPAP was 29.1(1.7) and TEI was 0.43(0.05) in the placebo group, while in the sildenafil group, both sPAP and TEI were reduced to 22(1.5) mm Hg and 0.23(0.03) (each p<0.005), respectively. We conclude that in healthy individuals, exposure to acute hypoxia and sojourns at high altitude result in a small but significant increase in sPAP accompanied by an impairment of right ventricular function. Sildenafil significantly decreases sPAP and improves right ventricular function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851140     DOI: 10.1016/j.resp.2007.07.005

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  11 in total

Review 1.  Portopulmonary hypertension and hepatopulmonary syndrome.

Authors:  Florence Aldenkortt; Marc Aldenkortt; Laurence Caviezel; Jean Luc Waeber; Anne Weber; Eduardo Schiffer
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

2.  Phosphodiesterase type 5 inhibitors for high-altitude pulmonary hypertension: a meta-analysis.

Authors:  Bo Jin; Xin-Ping Luo; Huan-Chun Ni; Hai-Ming Shi
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  The effects of sildenafil and acetazolamide on breathing efficiency and ventilatory control during hypoxic exercise.

Authors:  Sophie Lalande; Eric M Snyder; Thomas P Olson; Minelle L Hulsebus; Marek Orban; Virend K Somers; Bruce D Johnson; Robert P Frantz
Journal:  Eur J Appl Physiol       Date:  2009-04-01       Impact factor: 3.078

4.  The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases.

Authors:  Ghazwan Butrous
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16

5.  Sildenafil does not reliably improve exercise performance in hypoxia: a systematic review.

Authors:  Eric Alexander Carter; Keith Lohse; William Sheel; Michael Koehle
Journal:  BMJ Open Sport Exerc Med       Date:  2019-03-29

Review 6.  Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders.

Authors:  Akylbek Sydykov; Argen Mamazhakypov; Abdirashit Maripov; Djuro Kosanovic; Norbert Weissmann; Hossein Ardeschir Ghofrani; Akpay Sh Sarybaev; Ralph Theo Schermuly
Journal:  Int J Environ Res Public Health       Date:  2021-02-10       Impact factor: 3.390

7.  Short-term effects of sildenafil in the treatment of dogs with pulmonary hypertension secondary to degenerative mitral valve disease.

Authors:  Karun Saetang; Sirilak Disatian Surachetpong
Journal:  Vet World       Date:  2020-10-29

8.  Right Ventricular Response to Acute Hypoxia Exposure: A Systematic Review.

Authors:  Argen Mamazhakypov; Meerim Sartmyrzaeva; Nadira Kushubakova; Melis Duishobaev; Abdirashit Maripov; Akylbek Sydykov; Akpay Sarybaev
Journal:  Front Physiol       Date:  2022-01-12       Impact factor: 4.566

9.  Safety and Ergogenic Properties of Combined Aminophylline and Ambrisentan in Hypoxia.

Authors:  Thies Schroeder; Claude A Piantadosi; Michael J Natoli; Julie Autmizguine; Michael Cohen-Wolkowieczs; Karyn L Hamilton; Christopher Bell; Jelena Klawitter; Uwe Christians; David C Irwin; Robert J Noveck
Journal:  Clin Pharmacol Ther       Date:  2017-10-17       Impact factor: 6.875

10.  Preserved right ventricular function but increased right atrial contractile demand in altitude-induced pulmonary hypertension.

Authors:  Mahdi Sareban; Tabea Perz; Franziska Macholz; Bernhard Reich; Peter Schmidt; Sebastian Fried; Heimo Mairbäurl; Marc M Berger; Josef Niebauer
Journal:  Int J Cardiovasc Imaging       Date:  2020-03-09       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.